New Leaf Venture Partners is an early and growth-stage venture capital firm exclusively focused on healthcare technology. They invest across biopharmaceuticals, information convergence, medical devices, and life science tools, aiming to partner with innovative companies that have the potential for significant patient impact and strong commercial viability.
64% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Average disclosed round size is $40.7M (across 11 rounds with reported amounts).
Portfolio
11
Fund Size
$1.1B
Top Stage
Series C
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBrightInsight | Unknown | $13M | Jan 2026 |
 Electra Therapeutics | Series C | $183M | Oct 2025 |
 Neurava | Seed | $2.3M | Apr 2024 |
 Arine | Series B | $29M | Aug 2022 |
| MMesh++ | Seed | $4.9M | Oct 2021 |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
 Arvinas LLC | Series C | $55M | Apr 2018 |
 Kit Check | Series C | $15M | Jun 2016 |
 AiCure | Series A | $12.3M | Jan 2016 |
| TTigerText | Series B | $21M | Jan 2014 |
 Pearl Therapeutics Inc. | Series C | $69M | Oct 2011 |
Top Co-Investors
OrbiMed3 shared
RA Capital Management2 shared
Nextech Invest1 shared
Deerfield1 shared
Hillhouse Capital1 shared
Canaan Partners1 shared
MBX Capital1 shared
Katalyst Ventures1 shared
Vensana Capital1 shared
DigiTx Partners1 shared
Cigna Ventures1 shared
Pritzker Group Venture Capital1 shared
Tribeca Venture Partners1 shared
Shasta1 shared
Science1 shared
Kaiser Permanente Ventures1 shared
LionBird Ventures1 shared
Sands Capital1 shared
EQT Life Sciences1 shared
Sanofi Ventures1 shared
Last updated: 16 April 2026